Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
By S. Priori, C. Napolitano, M. Memmi, B. Colombi, F. Drago, M. Gasparini, L. Desimone, F. Coltorti, R. Bloise, R. Keegan and 4 more. Circulation, 2002
1,145 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/8701bef00d3ba43446a025f4ca12650487713aa3
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Bernard R. Chaitman
- C. Semsarian
- Rick A. Nishimura
- J. Halperin
- Jose Luis Zamorano
- J. Towbin
- Douglas P. Zipes
Citations in the corpus
- HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). (2011, background): “Approximately 30% of affected individuals have symptoms before age 10 and nearly 60% of patients have at least one syncopal episode before age 40.(76)”
- Ryanodine receptors: structure, expression, molecular details, and function in calcium release. (2010, background): “CPVT is characterized by stress-induced ventricular tachycardia (Marks et al. 2002; Priori et al. 2002; Laitinen et al. 2003).”
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “ade of life and are prompted by physical activity or emotional stress.(458) Diagnosis is challenging because patients with CPVT have a normal ECG and echocardiogram, therefore an exercise”
- HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). (2011, background): “Approximately 30% of affected individuals have symptoms before age 10 and nearly 60% of patients have at least one syncopal episode before age 40.(76)”
- ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “Although patients with this form of VT may not be overtly symptomatic, they are at risk for SCD (105).”